General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
CANbridge ×
CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.